| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 5.06 mm | 5.06 mm | 5.06 mm | 5.06 mm | 5.06 mm | 5.06 mm |
| Cash burn (monthly) | 1.96 mm | 868.33 k | 4.51 mm | 3.63 mm | 1.85 mm | 1.65 mm |
| Cash used (since last report) | 9.98 mm | 4.41 mm | 22.89 mm | 18.46 mm | 9.40 mm | 8.38 mm |
| Cash remaining | -4.92 mm | 650.31 k | -17.83 mm | -13.40 mm | -4.34 mm | -3.31 mm |
| Runway (months of cash) | -2.5 | 0.7 | -4.0 | -3.7 | -2.3 | -2.0 |
| 13F holders | Current |
|---|---|
| Total holders | 23 |
| Opened positions | 3 |
| Closed positions | 6 |
| Increased positions | 3 |
| Reduced positions | 4 |
| 13F shares | Current |
|---|---|
| Total value | 20.15 bn |
| Total shares | 27.12 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Halle Special Situations Fund | 7.13 mm | $0.00 |
| Norfield Capital | 6.60 mm | $3.10 mm |
| Broadwood Partners | 5.08 mm | $15.24 mm |
| Broadwood Capital | 4.93 mm | $14.05 bn |
| BIO Bio-Rad Laboratories | 1.20 mm | $3.04 mm |
| AWM Investment | 1.10 mm | $3.13 bn |
| Pura Vida Investments | 495.35 k | $1.41 bn |
| Vanguard | 245.39 k | $699.36 mm |
| Geode Capital Management | 103.98 k | $296.40 mm |
| BlackRock | 79.83 k | $227.53 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Feb 25 | Patrick W Smith | Common Stock, no par value | Other | Acquire J | Yes | No | 2.05 | 385,814 | 790.92 k | 3,258,485 |
| 7 Feb 25 | Patrick W Smith | Common Stock, no par value | Buy | Acquire P | Yes | No | 2.05 | 1,077,600 | 2.21 mm | 2,872,671 |
| 7 Feb 25 | Andrea S. James | Common Stock, no par value | Buy | Acquire P | No | No | 2.05 | 97,561 | 200.00 k | 151,231 |
| 6 Feb 25 | Broadwood Partners | Common Stock, no par value | Buy | Acquire P | Yes | No | 0 | 0 | 0.00 | 11,410,100 |
| 6 Feb 25 | Broadwood Partners | Common Stock, no par value | Buy | Acquire P | No | No | 2.05 | 4,505,488 | 9.24 mm | 11,410,100 |
| 6 Feb 25 | Broadwood Partners | Common Stock, no par value | Buy | Acquire P | Yes | No | 0 | 0 | 0.00 | 6,904,612 |
| 6 Feb 25 | Broadwood Partners | Common Stock, no par value | Buy | Acquire P | No | No | 2.05 | 660,207 | 1.35 mm | 6,904,612 |
| 4 Feb 25 | Patrick W Smith | Common Stock, no par value | Buy | Acquire P | Yes | No | 2.02 | 25 | 50.50 | 1,795,071 |
| 31 Jan 25 | Patrick W Smith | Common Stock, no par value | Buy | Acquire P | Yes | No | 2.01 | 890 | 1.79 k | 1,795,046 |
| 30 Jan 25 | Patrick W Smith | Common Stock, no par value | Buy | Acquire P | Yes | No | 2.01 | 318 | 639.18 | 1,794,156 |
